The TGA has published transition
arrangements for the reform of
its Orphan Drug Program, which is
undergoing its first review in almost
two decades.
The program is set to re-focus
on “the consideration of greatest
unmet need” with additional
eligibility criteria targeting life threatening
or seriously debilitating
conditions, significant benefit
over existing options and medical
plausibility - see tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 02 May 17 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 May 17
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.